Search

Taking inspiration from nature, the biomimetic concept has been integrated into drug delivery systems in cancer therapy. Disguised with cell membranes, the nanoparticles can acquire various functions of natural cells. The cell membrane-coating technology has pushed the limits of common nano-systems (fast elimination in circulation) to more effectively navigate within the body. Moreover, because of the various functional molecules on the surface, cell membrane-based nanoparticles (CMBNPs) are capable of interacting with the complex biological microenvironment of the tumor. Various sources of cell membranes have been explored to camouflage CMBNPs and different tumor-targeting strategies have been developed to enhance the anti-tumor drug delivery therapy. In this review article we highlight the most recent advances in CMBNP-based cancer targeting systems and address the challenges and opportunities in this field., Graphical abstract Nanoparticles can be cloaked with various types of cell membranes. The membrane-coating technology can prolong the circulation of nanomedicine in the bloodstream and show cancer-targeting potential by molecular recognition. This review provides an overview of cell membrane-based nanoparticles (CMBNPs) for tumor diagnosis and treatment.fx1